Why do men with non‑obstructive azoospermia (NOA) have smaller testicles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why Men with Non-Obstructive Azoospermia Have Smaller Testicles

Men with non-obstructive azoospermia (NOA) have smaller testicles because the severe deficit in spermatogenesis reflects primary testicular dysfunction with loss of functional testicular tissue, resulting in testicular atrophy. 1

Pathophysiological Mechanism

The reduced testicular volume in NOA directly reflects the underlying testicular pathology:

  • Primary testicular failure causes loss of seminiferous tubule function and subsequent atrophy of testicular tissue 1
  • The testicular parenchyma shrinks as spermatogenic cells are lost, leaving predominantly Sertoli cells or fibrotic tissue depending on the histopathological pattern 1
  • More severe histopathological patterns correlate with smaller testicular volumes - men with unfavorable patterns (Sertoli cell-only or early maturation arrest) have mean testicular volumes of 10.4 cc compared to 13.3 cc in those with favorable patterns (late maturation arrest or hypospermatogenesis) 2

Clinical Presentation

The European Association of Urology guidelines clearly state that men with NOA clinically present with:

  • Low testicular volume (typically <15 mL or <10 Prader orchidometer) 1
  • Elevated FSH values (usually >7.6 IU/L, often much higher) 3
  • Normal ejaculate volume (distinguishing NOA from obstructive causes) 1

This contrasts sharply with obstructive azoospermia, where testes are of normal size (~20 mL) because spermatogenesis is intact 3, 4.

Correlation with Severity

The relationship between testicular volume and testicular function severity is well-established:

  • Higher FSH levels (mean 22.9 IU/L) and smaller testicular volumes (mean 10.4 cc) are significantly associated with more severe (unfavorable) histopathological patterns 2
  • Men with favorable histopathology have lower FSH (mean 13.3 IU/L) and larger testicular volumes (mean 13.3 cc) 2
  • Men who develop testosterone deficiency after microdissection TESE have significantly lower baseline testicular volumes (6 Prader vs. 10 Prader in those maintaining eugonadal status) 5

Clinical Implications

The small testicular volume in NOA has important diagnostic and prognostic value:

  • Testicular atrophy combined with elevated FSH (>7.6 IU/L) strongly suggests spermatogenic failure rather than obstruction 3
  • However, testicular volume as a predictor of positive sperm retrieval has been inconsistent across studies, limiting its utility for surgical planning 1
  • Smaller testicular volumes at baseline predict higher risk of developing testosterone deficiency after surgical sperm retrieval procedures 5

Underlying Etiologies

The testicular atrophy in NOA results from various causes of primary testicular dysfunction:

  • Genetic abnormalities including Klinefelter syndrome (47,XXY) and Y chromosome microdeletions (AZFa, AZFb, AZFc) 3
  • Idiopathic testiculopathy with progressive loss of germ cells 6
  • Hypothalamic-pituitary-gonadal axis dysfunction in some cases 1

Common pitfall: Do not assume that smaller testicular volume always predicts failed sperm retrieval - focal spermatogenesis can occur even in severely atrophic testes, with sperm retrieval rates up to 50% reported in NOA patients 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.